PHILOGEN S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.6 EUR | -1.44% |
|
-2.83% | +11.35% |
| Jun. 06 | Futures up slightly on ECB day | AN |
| Jun. 05 | Mib bullish ahead of ECB; STM and Nexi soar | AN |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 582.2 | 569.4 | 745.9 | 830 | - | - |
| Enterprise Value (EV) 1 | 497 | 498.9 | 685.4 | 759.7 | 761.7 | 816.3 |
| P/E ratio | -36.8 x | -108 x | -123 x | 229 x | -18.1 x | -7.86 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 117 x | 20.9 x | 29.7 x | 9.69 x | 39.7 x | 21.2 x |
| EV / Revenue | 100 x | 18.3 x | 27.3 x | 8.87 x | 36.4 x | 20.8 x |
| EV / EBITDA | -33.3 x | 165 x | -132 x | 16.2 x | -27 x | -16.2 x |
| EV / FCF | -19.4 x | -56.7 x | -66.1 x | 231 x | -14.9 x | -7.85 x |
| FCF Yield | -5.15% | -1.76% | -1.51% | 0.43% | -6.7% | -12.7% |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 40,599 | 40,496 | 40,317 | 40,290 | - | - |
| Reference price 2 | 14.34 | 14.06 | 18.50 | 20.60 | 20.60 | 20.60 |
| Announcement Date | 3/28/22 | 3/28/23 | 3/27/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 6.345 | 4.964 | 27.3 | 25.12 | 85.69 | 20.92 | 39.19 |
| EBITDA 1 | - | -10.63 | -14.91 | 3.021 | -5.199 | 46.99 | -28.24 | -50.25 |
| EBIT 1 | - | -12.13 | -16.78 | 0.24 | -8.84 | 43.72 | -31.83 | -53.58 |
| Operating Margin | - | -191.16% | -337.93% | 0.88% | -35.19% | 51.02% | -152.14% | -136.72% |
| Earnings before Tax (EBT) 1 | - | -12.42 | -15.24 | -4.359 | -6.181 | 5.02 | -46 | -107 |
| Net income 1 | 1.402 | -13.28 | -15.72 | -5.376 | -6.161 | 3.85 | -46 | -107 |
| Net margin | - | -209.38% | -316.78% | -19.7% | -24.53% | 4.49% | -219.89% | -273.03% |
| EPS 2 | 0.0400 | -0.3700 | -0.3900 | -0.1300 | -0.1500 | 0.0900 | -1.140 | -2.620 |
| Free Cash Flow 1 | - | -16.62 | -25.58 | -8.792 | -10.37 | 3.29 | -51 | -104 |
| FCF margin | - | -261.94% | -515.35% | -32.21% | -41.28% | 3.84% | -243.79% | -265.37% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 7% | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | 85.45% | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/18/21 | 4/27/21 | 3/28/22 | 3/28/23 | 3/27/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2.52 | 3.83 | 1.952 | 3.012 | 20.18 | 7.116 | 22.52 | 2.599 | 3.5 | 126 | 9.808 | 12.33 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | - | -8.86 | -7.915 | 7.8 | -7.56 | 6.928 | -15.77 | -13.51 | 95.93 | -9.428 | -7.874 |
| Operating Margin | - | - | -453.89% | -262.78% | 38.65% | -106.24% | 30.76% | -606.69% | -385.94% | 76.15% | -96.13% | -63.86% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 9/30/21 | 4/27/21 | 9/28/21 | 3/28/22 | 9/28/22 | 3/28/23 | 9/28/23 | 3/27/24 | - | - | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 44.2 | - | - | - | - | - | - |
| Net Cash position 1 | - | - | 85.2 | 70.4 | 60.4 | 70.3 | 68.3 | 13.7 |
| Leverage (Debt/EBITDA) | - | -4.161 x | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -16.6 | -25.6 | -8.79 | -10.4 | 3.29 | -51 | -104 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 3.46 | 6.55 | 3.85 | 5.56 | 6 | 6 | 6 |
| Capex / Sales | - | 54.45% | 131.95% | 14.12% | 22.13% | 7% | 28.68% | 15.31% |
| Announcement Date | 2/18/21 | 4/27/21 | 3/28/22 | 3/28/23 | 3/27/24 | - | - | - |
1EUR in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
20.6
EUR
Average target price
23.5
EUR
Spread / Average Target
+14.08%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +11.35% | 897M | |
| +18.72% | 125B | |
| +14.19% | 108B | |
| -4.93% | 24.21B | |
| +3.23% | 22.78B | |
| -10.44% | 17.96B | |
| -41.74% | 16.43B | |
| -13.31% | 16.37B | |
| +2.44% | 13.58B | |
| +27.89% | 11.66B |
- Stock Market
- Equities
- PHIL Stock
- Financials Philogen S.p.A.
